Emerging evidence suggests that this pathway may interact with the PI3K/Akt/mTOR pathway, which is known as a modulator of cell growth, metabolism, and survival, and its dysregulation is often associated with leukemia, where it drives clonal expansion of malignant cells. This evidence concerns the gene AKT1 and leukemia.